Products

PermeaDerm®

Products

PermeaDerm®

Next-generation skin substitute designed for optimal wound healing1,2
PermeaDerm® is an FDA-cleared biosynthetic wound matrix for the treatment of partial-thickness wounds, surgical wounds, trauma wounds, donor sites, and the coverage of meshed autografts. Developed as a dual-layer skin substitute, PermeaDerm is comprised of an (1) outer slitted 2D silicone epidermal analogue, which facilitates the diffusion of gas and exudate to/from the wound, and an (2) inner 3D micro-support system with biocoating, which expedites adherence to the wound bed and supports early patient mobilization.
2
1

OUTER LAYER: SLITTED 2D SILICONE EPIDERMAL ANALOGUE

1

INNER LAYER: 3D MICRO-SUPPORT SYSTEM

2

Next-generation, skin substitute designed for optimal wound healing

PermeaDerm® is an FDA-cleared biosynthetic wound matrix for the treatment of partial-thickness wounds, surgical wounds, trauma wounds, donor sites, and the coverage of meshed autografts. Developed as a dual-layer skin substitute, PermeaDerm is comprised of an (1) outer slitted 2D silicone epidermal analogue, which facilitates the diffusion of gas and exudate to/from the wound, and an (2) inner 3D micro-support system with biocoating, which expedites adherence to the wound bed and supports early patient mobilization.

1
2

OUTER LAYER: SLITTED 2D SILICONE EPIDERMAL ANALOGUE

1

INNER LAYER: 3D MICRO-SUPPORT SYSTEM

2
Easy to use, versatile, and proven effective 1,2
See your patient through healing with flexibility and convenience with a proven next-generation technology1,2

Benefits of using PermeaDerm:

EASY TO USE

  • Simple, one-time application
  • Transparency allows at-a-glance wound assessment
  • Quickly adheres to wound surface
  • Flexible and adherent even on articulating joints
  • Highly water resistant

CONVENIENT AND VERSATILE

  • Suitable for wounds, donor sites, and over meshed autograft in all patients
  • Expanded treatment utility with large sheets (up to 2,903 cm²) and glove options
  • Less prone to stick to secondary dressings
  • Usable without a secondary dressing after adherence

PROVEN EFFECTIVE

  • Creates optimal healing environment, allowing epidermal migration
  • Customizable moisture management (defined porosity through stretch)
  • Provides bacterial barrier
  • Protects wounds from trauma

Actively supports healing

As shown in a partial-thickness burn (during early phases of healing).

Primary adherence occurs within 5 hours due to clot formation within inner 3D micro-support system.1-4

Image credit: Geras Healthcare productions

Demonstrated clinical advantages.
PermeaDerm creates an optimal environment to promote wound healing, typically within 7-14 days, after which it can be easily removed.
1-4

Product information and sizing

Contact your AVITA Medical sales representative for unit and carton ordering details or to place an order.

Product code Product Description Typical Use
PermeaDerm C
C2050500 PermeaDerm 5" x 5" Smaller wounds such as chronic wounds, surgical wounds, trauma wounds, draining wounds
PermeaDerm B
B1051000 PermeaDerm 5" x 10" Large wounds such as partial-thickness burns, trauma wounds, surgical wounds, donor sites, coverage over meshed autograft
B2101500 PermeaDerm 10" x 15"
B4153000 PermeaDerm 15" x 30"
PermeaDerm Glove
G1XS0000 PermeaDerm Glove XS Debrided partial-thickness hand burns
G2S00000 PermeaDerm Glove S
G3M00000 PermeaDerm Glove M
G4L00000 PermeaDerm Glove L
G5XL0000 PermeaDerm Glove XL

Resources that support you and your patients

REIMBURSEMENT SUPPORT SERVICES

AVITA Medical is committed to providing comprehensive PermeaDerm reimbursement support through Patient Access services. This program delivers the value of a direct, one-stop reimbursement resource for patients, surgeons, and hospital facilities.

 

Staffed by reimbursement experts, the program offers a range of services, including:

  • Pre-authorization services
  • Insurance appeals support
  • PermeaDerm reimbursement questions

 

To learn more, contact us at:

Telephone: (833) 674-1688

FAX: (661) 749-9430

Email: [email protected]

References

1. Woodroof A, Phipps R, Woeller C, et al. Evolution of a biosynthetic temporary skin substitute: A preliminary study. Eplasty. 2015;Jul 20:15:e30.
2. FDA PermeaDerm 510(k) Premarket Notification.
3. Greenwood JE. A randomized, prospective study of the treatment of superficial partial-thickness burns: AWBAT-S versus Biobrane. Eplasty. 2011;Feb 24:11:e10.
4. Greenwood JE, Clausen J, Kavanagh S. Experience with Biobrane: uses and caveats for success. Eplasty. 2009;Jun 26:9:e25.

Have questions?

Physicians: stay in touch

Sign Up to
Stay Connected